Major findings from the 4th Quality of Life and Cancer Clinical Trials Conference
The 4th Quality of Life and Cancer Clinical Trials Conference [...]
EORTC launches a new website
As recently announced in the newsletter of April 20th, 2017 [...]
Characterization of multifocal breast cancer using the 70-gene signature in clinical low-risk patients – A sub-analysis of the EORTC 10041/BIG 03-04 MINDACT trial GalleryCharacterization of multifocal breast cancer using the 70-gene signature in clinical low-risk patients – A sub-analysis of the EORTC 10041/BIG 03-04 MINDACT trial
Characterization of multifocal breast cancer using the 70-gene signature in clinical low-risk patients – A sub-analysis of the EORTC 10041/BIG 03-04 MINDACT trial
The primary results of the EORTC 10041/BIG 03-04 MINDACT trial [...]
Methodologies for conducting trials and other studies, including data handling and analysis at ESTRO-EORTC workshop
The EORTC contributes to ESTRO 36, Europe’s largest conference in [...]
New TRISTAN Project Leverages Potential of Imaging Techniques in Drug Safety Assessment
Brussels, April 12th 2017 – The Innovative Medicines Initiative (IMI) [...]
27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) – EORTC session: Infections in cancer patients
A session co-organised by European Organisation for research and Treatment [...]
Tackling brain tumours – EORTC proves value of academic collaboration in the research of brain cancer
A recently published article in Cancerworld focused on the therapeutic [...]
Long-term impact of imatinib on metastatic gastrointestinal stromal tumours (GIST)
The EORTC 62005 study, recently published in Journal of Clinical [...]
Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?
Ten-year follow-up results of the randomized phase II EORTC 40004 [...]
Could an early PET scan help better manage Hodgkin Lymphoma?
Adapting treatment based on results of early Positron-Emission Tomography (PET) [...]
